PolyPid to present surgical infection data at medical conference
PolyPid Ltd. (NASDAQ: PYPD) announced it will present data from its SHIELD II Phase 3 trial at the Surgical Infection ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
